Tao Qing-Qing, Sun Yi-Min, Liu Zhi-Jun, Yang Ping, Li Hong-Lei, Lu Shen-Ji, Wu Zhi-Ying
Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Neurobiol Aging. 2014 Aug;35(8):1956.e13-4. doi: 10.1016/j.neurobiolaging.2014.02.013. Epub 2014 Feb 20.
In recent years, several studies have reported calcium homeostasis modulator 1 (CALHM1) was a potential gene related to Alzheimer's disease (AD) susceptibility. However, whether CALHM1 p.P86L variation (rs2986017), a risk factor for AD is still controversial. Two independent studies have been performed in the Chinese population and the conclusions have not reached an agreement. In the present study, we performed a replication case-control study in 1301 Chinese subjects including 452 sporadic AD patients and 849 unrelated age and gender-matched controls, to determine whether this variation is a risk factor for AD in the Han Chinese population. We failed to replicate the positive association between the CALHM1 p.P86L variation and AD. In addition, we also examined p.P86L variation in a meta-analysis of 5 independent studies performed in Chinese and other Asian populations and negative association was found in total 2328 AD patients and 2865 controls. Our study suggests that CALHM1 p.P86L variation may not be an AD susceptibility factor in the Han Chinese population.
近年来,多项研究报告称钙稳态调节剂1(CALHM1)是与阿尔茨海默病(AD)易感性相关的一个潜在基因。然而,CALHM1 p.P86L变异(rs2986017)作为AD的一个风险因素,其情况仍存在争议。在中国人群中已开展了两项独立研究,但结论尚未达成一致。在本研究中,我们对1301名中国受试者进行了一项重复病例对照研究,其中包括452例散发性AD患者和849名年龄及性别匹配的无血缘关系对照,以确定该变异是否为汉族人群中AD的一个风险因素。我们未能重复出CALHM1 p.P86L变异与AD之间的阳性关联。此外,我们还在一项对中国及其他亚洲人群开展的5项独立研究的荟萃分析中检测了p.P86L变异,在总共2328例AD患者和2865名对照中发现了阴性关联。我们的研究表明,CALHM1 p.P86L变异可能不是汉族人群中AD的一个易感性因素。